Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.

Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, Wormenor CM, Amuah JE, Behnke AL, Höfler D, Pawlita M, Kaufmann AM.

PLoS One. 2019 Jun 27;14(6):e0218762. doi: 10.1371/journal.pone.0218762. eCollection 2019.

2.

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, Weinstein SJ, Albanes D, Brenner N, Hoffman-Bolton J, Kaaks R, Barricarte A, Tjønneland A, Sacerdote C, Trichopoulou A, Vermeulen RCH, Huang WY, Freedman ND, Brennan P, Waterboer T, Johansson M.

Ann Oncol. 2019 Jun 11. pii: mdz138. doi: 10.1093/annonc/mdz138. [Epub ahead of print]

PMID:
31185496
3.

Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.

Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR.

BMC Cancer. 2019 Jun 7;19(1):545. doi: 10.1186/s12885-019-5726-x.

4.

Soy and tea intake on cervical cancer risk: the Singapore Chinese Health Study.

Paul P, Koh WP, Jin A, Michel A, Waterboer T, Pawlita M, Wang R, Yuan JM, Butler LM.

Cancer Causes Control. 2019 Aug;30(8):847-857. doi: 10.1007/s10552-019-01173-3. Epub 2019 Jun 1.

PMID:
31154549
5.

Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study.

Aragonés N, Fernández de Larrea N, Pastor-Barriuso R, Michel A, Romero B, Pawlita M, Mayorgas-Torralba S, Martín V, Moreno V, Casabonne D, Castilla J, Fernandez-Tardón G, Dierssen-Sotos T, Capelo R, Salas D, Salcedo-Bellido I, Chirlaque MD, Brenner N, Pedraza M, Bessa X, Pérez-Gómez B, Butt J, Kogevinas M, Del Campo R, de Sanjosé S, Waterboer T, Pollán M.

Cancer Epidemiol. 2019 May 30;61:79-88. doi: 10.1016/j.canep.2019.05.008. [Epub ahead of print]

PMID:
31154081
6.

Human Papillomavirus Serologic Profiles of Selected Filipinos with Head and Neck Squamous Cell Carcinoma.

Albano PM, Salvador C, Orosa J, Racelis S, Leaño M, Michel A, Ramos JD, Holzinger D, Pawlita M.

J Pathol Transl Med. 2019 May 30. doi: 10.4132/jptm.2019.05.12. [Epub ahead of print]

7.

Comparison of multiplex-serology and ELISA based methods in detecting HPV16 L1 antibody responses in paired saliva and serum samples of healthy men.

Loimaranta V, Sievi K, Werner J, Pawlita M, Waterboer T, Butt J, Syrjänen S.

J Virol Methods. 2019 Aug;270:26-33. doi: 10.1016/j.jviromet.2019.04.007. Epub 2019 Apr 17.

PMID:
31004663
8.

Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.

Piontek T, Harmel C, Pawlita M, Carow K, Schröter J, Runnebaum IB, Dürst M, Graw F, Waterboer T.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180295. doi: 10.1098/rstb.2018.0295.

PMID:
30955486
9.

Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.

Loenenbach AD, Poethko-Müller C, Pawlita M, Thamm M, Harder T, Waterboer T, Schröter J, Deleré Y, Wichmann O, Wiese-Posselt M.

Int J Infect Dis. 2019 Jun;83:3-11. doi: 10.1016/j.ijid.2019.03.022. Epub 2019 Mar 20.

10.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18.

11.

Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.

Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.

Geburtshilfe Frauenheilkd. 2019 Feb;79(2):148-159. doi: 10.1055/a-0818-5440. Epub 2019 Feb 18.

12.

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.

Basu P, Muwonge R, Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Shastri SS, Pimple S, Anantharaman D, Prabhu PR, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Rameshwari Ammal Kannan TP, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Vashist S, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2019 Jun;7:75-81. doi: 10.1016/j.pvr.2019.01.004. Epub 2019 Jan 31.

13.

Validation of monoplex assays detecting antibodies against Corynebacterium diphtheriae and Clostridium tetani toxins, rubella virus and parvovirus B19 for incorporation into Multiplex Serology.

Brenner N, Butt J, Bomfim IL, Tabatabai J, Pawlita M, Schnitzler P, Waterboer T.

Methods. 2019 Apr 1;158:44-53. doi: 10.1016/j.ymeth.2019.01.013. Epub 2019 Jan 28.

PMID:
30703462
14.

Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.

Lang S, Schimansky S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness AR.

Head Neck. 2019 Jul;41(7):2074-2084. doi: 10.1002/hed.25660. Epub 2019 Jan 30.

PMID:
30698303
15.

Development and validation of HIV-1 Multiplex Serology.

Kranz LM, Gärtner B, Michel A, Pawlita M, Waterboer T, Brenner N.

J Immunol Methods. 2019 Mar;466:47-51. doi: 10.1016/j.jim.2019.01.007. Epub 2019 Jan 18.

PMID:
30660622
16.

Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.

Brenner N, Mentzer AJ, Butt J, Braband KL, Michel A, Jeffery K, Klenerman P, Gärtner B, Schnitzler P, Hill A, Taylor G, Demontis MA, Guy E, Hadfield SJ, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2019 Jan 7;14(1):e0210407. doi: 10.1371/journal.pone.0210407. eCollection 2019.

17.

Validation of Multiplex Serology detecting human herpesviruses 1-5.

Brenner N, Mentzer AJ, Butt J, Michel A, Prager K, Brozy J, Weißbrich B, Aiello AE, Meier HCS, Breuer J, Almond R, Allen N, Pawlita M, Waterboer T.

PLoS One. 2018 Dec 27;13(12):e0209379. doi: 10.1371/journal.pone.0209379. eCollection 2018.

18.

Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.

Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, Thomas S, Pring M, Pawlita M, Waterboer T, Ness A.

Head Neck. 2019 Apr;41(4):1053-1062. doi: 10.1002/hed.25543. Epub 2018 Dec 14.

PMID:
30549147
19.

Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Halec G, Waterboer T, Brenner N, Butt J, Hardy WD, DʼSouza G, Wolinsky S, Macatangay BJ, Pawlita M, Detels R, Martínez-Maza O, Hussain SK.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):e53-e63. doi: 10.1097/QAI.0000000000001916.

PMID:
30531297
20.

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Hyslop T, Um C, Grodstein F, Song M, Zeleniuch-Jacquotte A, Berndt S, Hildesheim A, Waterboer T, Pawlita M, Epplein M.

Gastroenterology. 2019 Jan;156(1):175-186.e2. doi: 10.1053/j.gastro.2018.09.054. Epub 2018 Oct 6.

PMID:
30296434
21.

DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.

Ambatipudi S, Langdon R, Richmond RC, Suderman M, Koestler DC, Kelsey KT, Kazmi N, Penfold C, Ho KM, McArdle W, Ring SM, Pring M, Waterboer T, Pawlita M, Gaunt TR, Davey Smith G, Thomas S, Ness AR, Relton CL.

Oral Oncol. 2018 Oct;85:87-94. doi: 10.1016/j.oraloncology.2018.08.021. Epub 2018 Sep 5.

22.

Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.

Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL, Taylor PR, Shimazu T, Yoo KY, Park SK, Kim J, Jee SH, Waterboer T, Pawlita M, You WC, Pan KF.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1472-1479. doi: 10.1158/1055-9965.EPI-18-0582. Epub 2018 Aug 29.

PMID:
30158280
23.

JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study.

Höcker B, Tabatabai J, Schneble L, Oh J, Thiel F, Pape L, Rusai K, Topaloglu R, Kranz B, Klaus G, Printza N, Yavascan O, Fichtner A, Krupka K, Bruckner T, Waldherr R, Pawlita M, Schnitzler P, Hirsch HH, Tönshoff B.

Pediatr Nephrol. 2018 Dec;33(12):2343-2352. doi: 10.1007/s00467-018-4029-9. Epub 2018 Jul 30.

PMID:
30058047
24.

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.

Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, Thamm M, Poethko-Müller C, Wichmann O, Wiese-Posselt M.

PLoS One. 2018 Jul 25;13(7):e0200267. doi: 10.1371/journal.pone.0200267. eCollection 2018.

25.

Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium.

Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, Hendrix LH, Huang LC, Waterboer T, Pawlita M, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1186-1194. doi: 10.1158/1055-9965.EPI-18-0249. Epub 2018 Jul 23.

PMID:
30038049
26.

Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.

Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M.

Dig Dis Sci. 2018 Oct;63(10):2765-2772. doi: 10.1007/s10620-018-5154-9. Epub 2018 Jun 8.

PMID:
29948559
27.

Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.

Ursu RG, Danciu M, Spiridon IA, Ridder R, Rehm S, Maffini F, McKay-Chopin S, Carreira C, Lucas E, Costan VV, Popescu E, Cobzeanu B, Ghetu N, Iancu LS, Tommasino M, Pawlita M, Holzinger D, Gheit T.

PLoS One. 2018 Jun 25;13(6):e0199663. doi: 10.1371/journal.pone.0199663. eCollection 2018.

28.

Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.

Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR.

Psychooncology. 2018 Sep;27(9):2245-2256. doi: 10.1002/pon.4816. Epub 2018 Jul 23.

29.

Predictors of oropharyngeal cancer survival in Europe.

Anantharaman D, Billot A, Waterboer T, Gheit T, Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Polesel J, Simonato L, Alemany L, Mena Cervigon M, Macfarlane TV, Znaor A, Thomson PJ, Robinson M, Canova C, Conway DI, Wright S, Healy CM, Toner ME, Pawlita M, Tommasino M, Brennan P.

Oral Oncol. 2018 Jun;81:89-94. doi: 10.1016/j.oraloncology.2018.04.016. Epub 2018 May 2.

30.

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial.

Michels J, Becker N, Suciu S, Kaiser I, Benner A, Kosaloglu-Yalcin Z, Agoussi S, Halama N, Pawlita M, Waterboer T, Eichmüller SB, Jäger D, Eggermont AMM, Zörnig I.

Oncoimmunology. 2018 Feb 12;7(6):e1428157. doi: 10.1080/2162402X.2018.1428157. eCollection 2018.

31.

Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N.

J Natl Cancer Inst. 2019 Feb 1;111(2):129-136. doi: 10.1093/jnci/djy084.

32.

Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression.

Hufnagel K, Lueong S, Willhauck-Fleckenstein M, Hotz-Wagenblatt A, Miao B, Bauer A, Michel A, Butt J, Pawlita M, Hoheisel JD, Waterboer T.

Sci Rep. 2018 May 14;8(1):7503. doi: 10.1038/s41598-018-25918-3.

33.

Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer.

Beynon RA, Lang S, Schimansky S, Penfold CM, Waylen A, Thomas SJ, Pawlita M, Waterboer T, Martin RM, May M, Ness AR.

Int J Cancer. 2018 Sep 1;143(5):1114-1127. doi: 10.1002/ijc.31416. Epub 2018 Apr 23.

34.

Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in India.

Bhatla N, Nene BM, Joshi S, Esmy PO, Poli URR, Joshi G, Verma Y, Zomawia E, Pimple S, Prabhu PR, Basu P, Muwonge R, Hingmire S, Sauvaget C, Lucas E, Pawlita M, Gheit T, Jayant K, Malvi SG, Siddiqi M, Michel A, Butt J, Sankaran S, Kannan TPRA, Varghese R, Divate U, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Kriplani A, Mishra G, Jadhav R, Thorat R, Tommasino M, Pillai MR, Sankaranarayanan R; Indian HPV vaccine study group.

Papillomavirus Res. 2018 Jun;5:163-171. doi: 10.1016/j.pvr.2018.03.008. Epub 2018 Mar 22.

35.

Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.

Bassig BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, Gao YT, Purdue MP, Xiang YB, Adams-Haduch J, Wang R, Brenner N, Waterboer T, Michel A, Ji BT, Hosgood HD, Rabkin CS, Yang G, Wong JYY, Zhang J, Hu W, Seow WJ, Chow WH, Pawlita M, Zheng W, Yuan JM, Lan Q, Rothman N.

Int J Cancer. 2018 Aug 1;143(3):570-579. doi: 10.1002/ijc.31385. Epub 2018 Apr 6.

PMID:
29574937
36.

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study.

Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, Basu P, Prabhu P, Bhatla N, Nene BM, Shaw J, Poli URR, Verma Y, Zomawia E, Pimple S, Tommasino M, Pawlita M, Gheit T, Waterboer T, Sehr P, Pillai MR; Indian HPV vaccine study group.

Vaccine. 2018 Aug 6;36(32 Pt A):4783-4791. doi: 10.1016/j.vaccine.2018.02.087. Epub 2018 Mar 15.

37.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

38.

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L.

Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20.

PMID:
29496041
39.

Is early life exposure to polyomaviruses and herpesviruses associated with obesity indices and metabolic traits in childhood?

Karachaliou M, de Sanjose S, Waterboer T, Roumeliotaki T, Vassilaki M, Sarri K, Leventakou V, Vafeiadi M, Chalkiadaki G, Stiakaki E, Michel A, Pawlita M, Kogevinas M, Chatzi L.

Int J Obes (Lond). 2018 Sep;42(9):1590-1601. doi: 10.1038/s41366-018-0017-1. Epub 2018 Jan 30.

PMID:
29445241
40.

Prevalence and stability of antibodies to thirteen polyomaviruses and association with cutaneous squamous cell carcinoma: A population-based study.

Antonsson A, Neale RE, O'Rourke P, Wockner L, Michel A, Pawlita M, Waterboer T, Green AC.

J Clin Virol. 2018 Apr;101:34-37. doi: 10.1016/j.jcv.2018.01.013. Epub 2018 Jan 31.

PMID:
29414185
41.

Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.

Butt J, Jenab M, Willhauck-Fleckenstein M, Michel A, Pawlita M, Kyrø C, Tjønneland A, Boutron-Ruault MC, Carbonnel F, Severi G, Kaaks R, Kühn T, Boeing H, Trichopoulou A, la Vecchia C, Karakatsani A, Panico S, Tumino R, Agnoli C, Palli D, Sacerdote C, Bueno-de-Mesquita HBA, Weiderpass E, Sánchez MJ, Bonet Bonet C, Huerta JM, Ardanaz E, Bradbury K, Gunter M, Murphy N, Freisling H, Riboli E, Tsilidis K, Aune D, Waterboer T, Hughes DJ.

Int J Cancer. 2018 Jul 15;143(2):245-252. doi: 10.1002/ijc.31283. Epub 2018 Feb 14.

42.

Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement.

Cason C, Monasta L, Zanotta N, Campisciano G, Maestri I, Tommasino M, Pawlita M, Villani S, Comar M, Delbue S.

J Neurovirol. 2018 Jun;24(3):314-322. doi: 10.1007/s13365-017-0612-2. Epub 2018 Jan 12.

43.

Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China.

Varga MG, Wang T, Cai H, Xiang YB, Gao YT, Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO, Epplein M.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):342-344. doi: 10.1158/1055-9965.EPI-17-1084. Epub 2017 Dec 20.

44.

Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.

Teras LR, Gapstur SM, Maliniak ML, Jacobs EJ, Gansler T, Michel A, Pawlita M, Waterboer T, Campbell PT.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):219-223. doi: 10.1158/1055-9965.EPI-17-0407. Epub 2017 Dec 18.

45.

Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations.

Rahman S, Giuliano AR, Rollison DE, Pawlita M, Waterboer T, Villa LL, Lazcano Ponce E.

Papillomavirus Res. 2017 Dec;4:54-57. doi: 10.1016/j.pvr.2017.08.001. Epub 2017 Aug 2.

46.

Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.

Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D.

Int J Cancer. 2018 Apr 1;142(7):1361-1368. doi: 10.1002/ijc.31167. Epub 2017 Dec 4.

47.

Smoking and subsequent human papillomavirus infection: a mediation analysis.

Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N.

Ann Epidemiol. 2017 Nov;27(11):724-730.e1. doi: 10.1016/j.annepidem.2017.10.004. Epub 2017 Oct 17.

48.

Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.

Schmidt K, Butt J, Mauter P, Vogel K, Erles-Kemna A, Pawlita M, Nicklas W.

PLoS One. 2017 Oct 31;12(10):e0187174. doi: 10.1371/journal.pone.0187174. eCollection 2017.

49.

Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.

Baboci L, Holzinger D, Boscolo-Rizzo P, Tirelli G, Spinato R, Lupato V, Fuson R, Schmitt M, Michel A, Halec G, Da Mosto MC, Pawlita M, Del Mistro A.

Papillomavirus Res. 2016 Dec;2:133-140. doi: 10.1016/j.pvr.2016.07.002. Epub 2016 Jul 16.

50.

Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

Mena M, Lloveras B, Tous S, Bogers J, Maffini F, Gangane N, Kumar RV, Somanathan T, Lucas E, Anantharaman D, Gheit T, Castellsagué X, Pawlita M, de Sanjosé S, Alemany L, Tommasino M; HPV-AHEAD study group.

PLoS One. 2017 Oct 16;12(10):e0184520. doi: 10.1371/journal.pone.0184520. eCollection 2017.

Supplemental Content

Loading ...
Support Center